Annual Report of 2024-25
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Deccan Health Care Ltd (BSE Scrip Code: 542248) has submitted its Annual Report for the financial year 2024-25 along with the Notice of the 29th Annual General Meeting to BSE. The 29th AGM is scheduled for Tuesday, 30 September 2025 at 03:00 PM, held through video conferencing. Key items on the AGM agenda include adoption of audited standalone and consolidated financial statements for FY ended 31 March 2025, re-appointment of Meenakshi Gupta as director (retiring by rotation), appointment of M/S. M.R. Bhatia & Co as Secretarial Auditor for five years, and re-appointment of Ruchi Khattar as Independent Director for a second term of five years. The company has not declared any dividend for FY 2024-25. The register of members will be closed from 22 September to 30 September 2025. The report highlights operational focus on nutrifoods and self-care segments, with the company's flagship Iron-Enriched Fruit Bar initiative supporting the government's Anemia Mukt Bharat programme.
Routine regulatory filing — no immediate effect on stock price. Shareholders should review the Annual Report and exercise their voting rights on the proposed resolutions during the remote e-voting window (27-29 September 2025). The absence of a dividend means no income for shareholders in FY 2024-25.